logo

Programme Overview

MS Nurse Professional is a pan-European, modular, CME-accredited training curriculum for nurses, providing up-to-date information on MS. It has been developed to support the attainment of necessary skills for MS Nurses and also to set the benchmark for core competencies leading to improved consistency of practice, irrespective of geography, to further benefit people with MS.

Authored by leading experts in the field of MS, this online programme provides five comprehensive, interactive modules. Each module focuses on a different aspect of MS and together they form the core training curriculum. Additional elements are also available, including nursing tips and clinical case-based scenarios, to help the learner apply the knowledge acquired to real-world clinical practice.

MS Nurse Professional offers international and, where available, country specific accreditation. Nursing education credits are available and are dependent upon completion of all activities available on MS Nurse Professional. This accreditation should not be confused with the certification examination offered by the Multiple Sclerosis Nursing International Certification Board (MSNICB) and supported by the IOMSN. Please click here if you would like to view the certfication examination as an activity independent of this project.

Target Audience

This activity has been developed to meet the educational needs of nurses who have an interest in optimising the management of people with MS.

Learning Objectives

The overall objectives of MS Nurse Professional are to:

  • Enhance the competence / performance of MS Nurses so they meet national and pan-European standards set for their specialty which will positively impact on patient care and well-being

Please see individual modules for more detailed, specific learning objectives relating to each module

Accreditation Statement



This programme has been accredited by the Royal College of Nursing (RCN) Centre for Professional Accreditation until May 23rd 2018. Accreditation applies only to the educational content of the programme and does not apply to any product.


This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of International Continuing Nursing Education Credits (ICNECs) until 1 March 2019.


This continuing education activity has been Category 1 approved by the Bord Altranais agus Cnáimhseachais na hÉireann (Nursing and Midwifery Board of Ireland (NMBI)) for the award of continuing education units from 23 August 2013 – 4 November 2017.

Credit Designation

The Royal College of Nursing, the International Council of Nursing and the Nursing and Midwifery Board of Ireland designate this enduring material for a maximum of 30 credits/education units. On completion of this course you will be able to download a Virtual College certificate.

Duration

It is estimated that this training curriculum will take approximately 30 hours to complete (depending on learning speed). As an e-learning curriculum you can complete this training in convenient stages and revisit whenever you wish. The system will record your progress.

Method of Participation

This is an online course, all the training will be taken through your browser window. There will be no face-to-face sessions with instructors nor will you receive any training material through the post. Should you wish, you may download, save and print out any pages of the training modules. You can also revisit the training material at any time, even after you have completed the course.

Training modules can be taken in any order and each module may be PAUSED and RESUMED at any stage. We do recommend the modules are taken in sequence, and that you take time while working through a module, and between modules, to consider the information you have learnt, and to review the additional elements which add value and help place the information into real world clinical practice. When all modules in the training curriculum have been completed successfully, our system will register this and automatically record that you have successfully completed the curriculum.

There are no fees for participating and receiving CME credit for this activity. Participants must; (1) read the learning objectives and faculty disclosures, (2) participate in the entire educational activity, consisting of 5 core modules, (3) complete the post-test for each module by recording the best answer to each question, and (4) complete the online evaluation form. Upon successful completion of all 5 post-tests (75% or better) and online evaluation forms, you will be provided with a statement of credit which you can download, save and print.

Disclosure of Unlabelled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the EMEA or local regulatory authorities. The RCN, ICN, NMBI, EANN, EMSP, RIMS, IOMSN, SCI, and Novartis do not recommend the use of any agent outside of the labelled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of RCN, ICN, NMBI, EANN, EMSP, RIMS, IOMSN, SCI and Novartis. Please refer to the official prescribing information in your own country for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by nurses without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

This activity is supported by an educational grant from Novartis Pharma AG, Biogen, genzyme, Teva, Bayer healthcare, Roche, Merck Serono.